Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Trial Designed to Evaluate the Repeatability and Reproducibility of the Intelon BOSS(tm) System

NCT05423041 is registered in ClinicalTrials.gov with Intelon Optics, Inc as lead sponsor.

NCT NCT05423041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05423041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Trial Designed to Evaluate the Repeatability and Reproducibility of the Intelon BOSS(tm) System
Lead sponsor
Intelon Optics, Inc
Phase
Not applicable
Overall status
Completed
Start date
May 14, 2022
Completion date
September 13, 2022
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal crosslinking, corneal transplant, healthy eyes